Clinical studies recruiting near Manila

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
Phase 3 · Philippine General Hospital ( Site 0700) · Merck Sharp & Dohme LLC · NCT07044297 Prospective Observational Study On The Impact Of Nebilet In Blood Pressure Control In Hypertensive Patients (HYIMPACT)
Phase N/A · A.Menarini Asia-Pacific Holdings Pte Ltd · NCT06938516 A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosc
Phase 3 · Manila Doctors Hospital · Boehringer Ingelheim · NCT07220083 Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Phase 3 · University of Santo Tomas · Kura Oncology, Inc. · NCT07007312 The Purpose of This Clinical Study is to Evaluate Optimized Maximum Plus for Maximum Visual Acuity (MPMVA) Refractive Te
Phase N/A · Peregrine Eye Laser Institute · Hoya Surgical Optics, Inc. · NCT07595432 Validation of the Lupus Low Disease Activity State (LLDAS) in the Asia Pacific Region
Phase N/A · Joint and Bone Center, University of Santo Tomas Hospital · Monash University · NCT03138941 Clinical and Molecular Studies in Families With Inherited Eye Disease
Phase N/A · University of the Philippines · National Eye Institute (NEI) · NCT02771236 Comparing Conventional Continuous Ambulatory Peritoneal Dialysis Prescription (C-CAPD) With Modified-CAPD (M-CAPD) Presc
NA · Philippine General Hospital · National University Health System, Singapore · NCT07134595 An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Phase 3 · Research Site · AstraZeneca · NCT05952557 A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants Wi
Phase 3 · Research Site · AstraZeneca · NCT05211895 A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Years of Age and Older Wi
Phase 2 · Research Site · AstraZeneca · NCT07088926 Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Dee
Phase 3 · Anthos Investigational Site 3605 · Anthos Therapeutics, Inc. · NCT05712200 Monitoring Drug Efficacy in Patients with Alzheimer's Disease
Phase N/A · Philippine General Hospital · University of the Philippines · NCT05801380 A Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB12 (Proposed Pembrolizumab Biosimilar) to
Phase 3 · Site 203007 · mAbxience Research S.L. · NCT06687369 Preventive Strategies for Early and Late Complications of Leptospirosis
Phase 2 · Institute of Human Genetics, National Institutes of Health - · National Kidney and Transplant Institute, Philippines · NCT07127718 iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases
Phase N/A · Research Site · AstraZeneca · NCT03549754 A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD
Phase 3 · Hoffmann-La Roche · NCT05878769 Influenza Vaccine (Split Virion), Inactivated, Quadrivalent in Pregnant Women
Phase 3 · University of the Philippines - Philippine General Hospital · Sinovac Biotech Co., Ltd · NCT07211152 Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Phase 3 · Research Site · AstraZeneca · NCT06307652 A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doub
Phase 3 · Research Site · AstraZeneca · NCT06417814 Bacterial Cellulose-monolaurin Hydrogel for Acute Radiation Dermatitis
NA · Philippine General Hospital · University of the Philippines · NCT05079763 A Safety and Immunogenicity Study of CHIKV VLP Vaccine in Children.
Phase 3 · Institute of Child Health and Human Development, University · Bavarian Nordic · NCT07003984 A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
Phase 3 · Research Site · AstraZeneca · NCT05774951 A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
Phase 3 · Manila Doctors Hospital · Boehringer Ingelheim · NCT07497087 A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopul
Phase 3 · Research Site · AstraZeneca · NCT06283966 A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D
Phase 3 · Research Site · AstraZeneca · NCT06883305 A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in
Phase 3 · Manila Doctors Hospital ( Site 5701) · Merck Sharp & Dohme LLC · NCT06841354 A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a
Phase 3 · Research Site · AstraZeneca · NCT07000357 Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic H
Phase 1 · Research Site · AstraZeneca · NCT04686305 A Study to Evaluate V181 Dengue Vaccine in Healthy Participants 2 to 17 Years of Age (V181-005/MOBILIZE-1)
Phase 3 · Philippine General Hospital ( Site 0041) · Merck Sharp & Dohme LLC · NCT07013487

Look up another city

Look up another condition